Nasal allergen challenge and immunotherapy control
- PMID: 9657024
Nasal allergen challenge and immunotherapy control
Abstract
Nasal allergen challenges, despite not reproducing exactly natural allergen exposure, are a very useful method to understand the complex cellular kinetics and cellular interactions that occur in allergic rhinitis. Cell-specific soluble mediator measurements can give useful diagnosis information as well as complementary information regarding the monitoring of specific immunotherapy. In this article we present data concerning eosinophil cationic protein and tryptase measurements after nasal allergen and the influence of specific immunotherapy on nasal peak flow before and 1, 2 and 3 years after starting immunotherapy.
Similar articles
-
Nasal allergen challenge and mediators release.Allerg Immunol (Paris). 1997 Nov;29(9):269-71. Allerg Immunol (Paris). 1997. PMID: 9435923 Review.
-
Kinetics of eosinophil cationic protein release in mite-allergic rhinitis after specific nasal provocation.Allerg Immunol (Paris). 1998 Apr;30(4):104, 107-11. Allerg Immunol (Paris). 1998. PMID: 9631691
-
Relationship between nasal hyperreactivity, mediators and eosinophils in patients with perennial allergic rhinitis and controls.Clin Exp Allergy. 1996 Aug;26(8):903-8. Clin Exp Allergy. 1996. PMID: 8877155
-
Basophil and eosinophil accumulation and mast cell degranulation in the nasal mucosa of patients with hay fever after local allergen provocation.J Allergy Clin Immunol. 2000 Oct;106(4):677-86. doi: 10.1067/mai.2000.109621. J Allergy Clin Immunol. 2000. PMID: 11031338
-
Nasal provocation and immunotherapy.J Investig Allergol Clin Immunol. 1999 Sep-Oct;9(5):283-7. J Investig Allergol Clin Immunol. 1999. PMID: 10582195 Review.